Early rehabilitation management strategy for septic arthritis of the knee - 05/06/22
Highlights |
• | Early rehabilitation is needed for septic arthritis in native knee. |
• | A four-phase rehabilitation strategy has been developed: recovery of joint amplitudes, muscle recovery without resistance, recovery with technical aid (crutches, canes), continuation of the rehabilitation (pursuit of muscle, articular, proprioceptive and endurance recovery). |
• | Prospective validation of this strategy is needed to confirm its feasibility and effectiveness. |
Abstract |
Objectives |
Early rehabilitation management of septic arthritis in the native knee is not standardized. In this context, it is necessary to develop and validate an early rehabilitation strategy.
Materiel and methods |
Based on the formalized HAS consensus method, a 4-phase rehabilitation strategy has been developed: recovery of joint amplitudes, muscle recovery without resistance, recovery with technical aid (crutches, canes), continuation of the rehabilitation (pursuit of muscle, articular, proprioceptive and endurance recovery).
Results |
It was submitted to the opinion of multidisciplinary experts (PMR, general practitioner, rheumatologist, infectiologist, orthopedic surgeon, physiotherapist). Nearly 80% of the items were directly validated, with only five items scoring less than 5/10. Modifications were made in order to obtain a final version of the protocol.
Conclusion |
Use of a rigorous methodology enabled a consensual strategy for early rehabilitation management to be developed. Prospective validation of this strategy is needed to confirm its feasibility and effectiveness.
Le texte complet de cet article est disponible en PDF.Keywords : Septic arthritis, Rehabilitation, Early mobilization, Knee, Physiotherapy
Abbreviations : HAS, PMR, SPILF
Plan
Vol 52 - N° 3
P. 170-174 - mai 2022 Retour au numéro
Article précédent
- Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up
- S. Seang, O. Itani, G. Monsel, B. Abdi, A.G. Marcelin, M.A. Valantin, R. Palich, A. Fayçal, V. Pourcher, C. Katlama, R. Tubiana
- Antibiotics in end of life: The driving factors
- Serge Sirvain, Mailys Durand, Alain Putot, Emmanuel Forestier, Gaetan Gavazzi, Thibaut Fraisse, GInGer SPILF SFGG
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?